Search research articles
Contact Us
Filters
Showing results (111-120 of 346) with videos related to
Page
of 35
Sort By:
Journal of Hematology & Oncology
|
May 14, 2025
Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab
Nicholas J Short, Hagop Kantarjian, Ken Furudate, et al.
American Journal of Hematology
|
June 23, 2021
Impact of Philadelphia chromosome-like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER study
Elias Jabbour, Keyur Patel, Nitin Jain, et al.
Cancer
|
February 21, 2025
Treatment-free remission in nontransplanted patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Eitan Kugler, Hagop Kantarjian, Elias Jabbour, et al.
Acta Haematologica
|
November 25, 2020
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant
Bachar Samra, Hagop M Kantarjian, Koji Sasaki, et al.
Haematologica
|
December 10, 2020
Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemia
Iman Abou Dalle, Ronald Paranal, Jabra Zarka, et al.
Blood Cancer Journal
|
October 21, 2025
Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL
Nicholas J Short, Elias Jabbour, Walid Macaron, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 21, 2017
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia
Rita Assi, Hagop Kantarjian, Nicholas J Short, et al.
American Journal of Hematology
|
April 12, 2024
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy
Nicholas J Short, Elias Jabbour, Lewis F Nasr, et al.
American Journal of Hematology
|
January 6, 2025
Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
Hagop Kantarjian, Nicholas J Short, Nitin Jain, et al.
Cancer
|
April 9, 2026
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia
Hagop Kantarjian, Wei Qiao, Nitin Jain, et al.
Page
of 35
Search research articles
Search
Showing results (111-120 of 346) with videos related to
Sort By:
Page
of 35
Journal of Hematology & Oncology
|
May 14, 2025
Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab
Nicholas J Short, Hagop Kantarjian, Ken Furudate, et al.
American Journal of Hematology
|
June 23, 2021
Impact of Philadelphia chromosome-like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER study
Elias Jabbour, Keyur Patel, Nitin Jain, et al.
Cancer
|
February 21, 2025
Treatment-free remission in nontransplanted patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Eitan Kugler, Hagop Kantarjian, Elias Jabbour, et al.
Acta Haematologica
|
November 25, 2020
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant
Bachar Samra, Hagop M Kantarjian, Koji Sasaki, et al.
Haematologica
|
December 10, 2020
Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemia
Iman Abou Dalle, Ronald Paranal, Jabra Zarka, et al.
Blood Cancer Journal
|
October 21, 2025
Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL
Nicholas J Short, Elias Jabbour, Walid Macaron, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 21, 2017
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia
Rita Assi, Hagop Kantarjian, Nicholas J Short, et al.
American Journal of Hematology
|
April 12, 2024
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy
Nicholas J Short, Elias Jabbour, Lewis F Nasr, et al.
American Journal of Hematology
|
January 6, 2025
Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
Hagop Kantarjian, Nicholas J Short, Nitin Jain, et al.
Cancer
|
April 9, 2026
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia
Hagop Kantarjian, Wei Qiao, Nitin Jain, et al.
Page
of 35